Viera Lukacova, Ph.D.

Chief Scientist
Simulations Plus, Inc.

Poster(s):

• (T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
  Tuesday, October 22, 2024

  9:30 AM – 10:30 AM MT

• (T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
  Tuesday, October 22, 2024

  9:30 AM – 10:30 AM MT

• (M1030-02-09) Integration of Gut Microbiome Metabolism in a PBBM-PBPK Model: Its Impact on the Sulfasalazine Absorption
  Monday, October 21, 2024

  10:30 AM – 11:30 AM MT

• (W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
  Wednesday, October 23, 2024

  12:30 PM – 1:30 PM MT

• (T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
  Tuesday, October 22, 2024

  2:30 PM – 3:30 PM MT

• (M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
  Monday, October 21, 2024

  3:30 PM – 4:30 PM MT